
Wuhan Wansheng Biotechnology
Finnrick has tested 56 samples from Wuhan Wansheng Biotechnology across 3 products.
Finnrick Vendor Profile
to
Wuhan Wansheng Biotechnology
Tracking 3 products
56 total samples tested
Last test 25 Nov 2025
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 34 | 4 Aug 2025 | 25 Nov 2025 | |||||
| Tesamorelin | 8 | 11 Aug 2025 | 25 Nov 2025 | |||||
| Tirzepatide | 14 | 31 Aug 2025 | 4 Nov 2025 | |||||
Most recent Wuhan Wansheng Biotechnology tests
Samples are tested in commercial labs
56
tests
3
products
Scores
AVGMINMAX
First
4 Aug 2025
Last
25 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Nov 2025 | Tesamorelin | View | 10mg | 9.080mg | -9.2% | 71.37% | 1Tes10PD | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 25 Nov 2025 | Retatrutide | View | 30mg | 30.100mg | +0.3% | 99.95% | (no batch ID) | No Label / Silver Crimp / Clear Yellow Cap | Lab E | Public | |
| 25 Nov 2025 | Tesamorelin | View | 10mg | 5.070mg | -49.3% | 47.46% | (no batch ID) | (no data) | Lab E | Public | |
| 25 Nov 2025 | Retatrutide | View | 50mg | 47.600mg | -4.8% | 99.95% | wwb-25-11 | White Label / Black Crimp / Clear Blue Cap | Lab E | Public | |
| 18 Nov 2025 | Retatrutide | View | 20mg | 17.000mg | -15.0% | 99.80% | July 15 2025 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 17 Nov 2025 | Retatrutide | View | 30mg | 28.100mg | -6.3% | 99.72% | (no batch ID) | No Label / Silver Crimp / Clear Yellow Cap | Lab E | Public | |
| 4 Nov 2025 | Retatrutide | View | 20mg | 20.700mg | +3.5% | 99.90% | (no batch ID) | Silver Label / Silver Crimp / Violet Cap | Lab G | Public | |
Corrections
- 5 Nov 2025: Retatrutide
- These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.